Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 140 citing articles:

Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
Richard Lee Barrett, Ellen Puré
eLife (2020) Vol. 9
Open Access | Times Cited: 245
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 177
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 140
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Shamin Azwar, Heng Fong Seow, Maha Abdullah, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 854-854
Open Access | Times Cited: 110
Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment
Jeong-Yeon Mun, Sun‐Hee Leem, Jun‐Ho Lee, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 71
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 117
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Denisa Baci, Annalisa Bosi, Matteo Gallazzi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3125-3125
Open Access | Times Cited: 100
Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Jin Li, Diane J. Burgess
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2110-2124
Open Access | Times Cited: 95
Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
Shuo Zhang, Weijian Liu, Binwu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 71
Modulation of the tumor microenvironment (TME) by melatonin
Mu Qi, Masoud Najafi
European Journal of Pharmacology (2021) Vol. 907, pp. 174365-174365
Closed Access | Times Cited: 68
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors
Matteo Gallazzi, Denisa Baci, Lorenzo Mortara, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 58
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
Mu Qi, Masoud Najafi
International Immunopharmacology (2021) Vol. 98, pp. 107895-107895
Closed Access | Times Cited: 56
Potential Application of Exosomes in Vaccine Development and Delivery
Md Nurul Huda, Md Nurunnabi
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2635-2671
Open Access | Times Cited: 49
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
Jiawei Shi, Junwei Liu, Xiaoxuan Tu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003133-e003133
Open Access | Times Cited: 44
Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Lizhen He, Jianfu Zhao, Hongjun Li, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 27
Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors
Keiko Taniguchi‐Ponciano, Sergio Andonegui-Elguera, Eduardo Peña-Martínez, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
Alia Ghoneum, Sameh Almousa, Bailey Warren, et al.
Seminars in Cancer Biology (2021) Vol. 77, pp. 83-98
Open Access | Times Cited: 51
Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors
Taehoon Sim, Bongseo Choi, Soon Woo Kwon, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12780-12793
Closed Access | Times Cited: 50
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
Emre Balta, Guido H. Wabnitz, Yvonne Samstag
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5736-5736
Open Access | Times Cited: 48
Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy
Clementina Sansone, Antonino Bruno, Concetta Piscitelli, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 231-231
Open Access | Times Cited: 42
Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells
Noëlla Lopes, Justine Galluso, Bertrand Escalière, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100812-100812
Open Access | Times Cited: 29
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access
Innate immune cells in vascular lesions: mechanism and significance of diversified immune regulation
Jinjing Wu, Y. Qian, Yang Kuang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Bistable dynamics of TAN-NK cells in tumor growth and control of radiotherapy-induced neutropenia in lung cancer treatment
Donggu Lee, Sun‐Ju Oh, Sean E. Lawler, et al.
Mathematical Biosciences & Engineering (2025) Vol. 22, Iss. 4, pp. 744-809
Open Access
Page 1 - Next Page

Scroll to top